The MiniMed 780G Advanced Hybrid Closed Loop System. Credit: Medtronic.

The US Food and Drug Administration (FDA) has granted approval for Medtronic’s insulin pump, the MiniMed 780G system.

The new insulin pump system comes with the Guardian 4 sensor which eliminates the need for finger pricks while in SmartGuard mode.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

It is claimed to be the only FDA-approved insulin pump system with meal-detection technology that automatically adjusts and corrects glucose levels every five minutes for basal (background) and bolus (mealtime) insulin needs.

The MiniMed 780G system facilitates the lowest glucose target setting where users can set as low as a 100mg/dL dose in any automated insulin pump currently available in the market.

This setting closely mimics the average glucose delivery of people without diabetes and will automatically adjust and correct basal insulin based on the set target.

Medtronic Diabetes president and executive vice-president Que Dallara said: “Mealtimes prove to be one of the biggest challenges for people living with type 1 diabetes and now for the first time, the MiniMed 780G system addresses this unmet need with automatic, real-time insulin corrections.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“A lot can happen to blood sugars in the span of an hour or even just a few minutes, so we’ve designed our system for real life – the algorithm adapts to the user and helps compensate for everyday challenges that are quite common around mealtimes… we’re excited to deliver a system with ease of use at the forefront.”